← FDA Drug Approvals (Drugs@FDA)
REZIPRES
NDA · New Drug Application · Sponsor: DR REDDYS LABS SA · Approved 2021-06-14
Drug application
- FDA Application #
NDA213536- Application type
- New Drug Application
- Brand name
- REZIPRES
- Generic name
- Ephedrine Hydrochloride
- Active ingredients
- EPHEDRINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- DR REDDYS LABS SA
- First approval
- 2021-06-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown